全文获取类型
收费全文 | 2239篇 |
免费 | 204篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 72篇 |
儿科学 | 58篇 |
妇产科学 | 43篇 |
基础医学 | 322篇 |
口腔科学 | 52篇 |
临床医学 | 296篇 |
内科学 | 395篇 |
皮肤病学 | 74篇 |
神经病学 | 140篇 |
特种医学 | 58篇 |
外科学 | 446篇 |
综合类 | 19篇 |
一般理论 | 1篇 |
预防医学 | 157篇 |
眼科学 | 25篇 |
药学 | 153篇 |
中国医学 | 1篇 |
肿瘤学 | 137篇 |
出版年
2022年 | 24篇 |
2021年 | 34篇 |
2020年 | 30篇 |
2019年 | 24篇 |
2018年 | 56篇 |
2017年 | 39篇 |
2016年 | 59篇 |
2015年 | 70篇 |
2014年 | 98篇 |
2013年 | 130篇 |
2012年 | 88篇 |
2011年 | 72篇 |
2010年 | 74篇 |
2009年 | 85篇 |
2008年 | 61篇 |
2007年 | 79篇 |
2006年 | 66篇 |
2005年 | 68篇 |
2004年 | 62篇 |
2003年 | 63篇 |
2002年 | 54篇 |
2001年 | 58篇 |
2000年 | 52篇 |
1999年 | 59篇 |
1998年 | 39篇 |
1997年 | 22篇 |
1996年 | 25篇 |
1995年 | 28篇 |
1994年 | 20篇 |
1993年 | 20篇 |
1992年 | 47篇 |
1991年 | 42篇 |
1990年 | 44篇 |
1989年 | 41篇 |
1988年 | 57篇 |
1987年 | 40篇 |
1986年 | 35篇 |
1985年 | 28篇 |
1984年 | 29篇 |
1983年 | 33篇 |
1982年 | 21篇 |
1981年 | 22篇 |
1979年 | 25篇 |
1978年 | 22篇 |
1976年 | 19篇 |
1974年 | 19篇 |
1973年 | 19篇 |
1971年 | 19篇 |
1970年 | 19篇 |
1967年 | 19篇 |
排序方式: 共有2449条查询结果,搜索用时 0 毫秒
81.
Oscar Bernal‐Pacheco MD Genko Oyama MD PhD Kelly D. Foote MD Yunfeng E. Dai MS Samuel S. Wu PhD Charles E. Jacobson IV BS Natlada Limotai MD Pamela R. Zeilman ARNP Janet Romrell PA Nelson Hwynn DO Ramon L. Rodriguez MD Irene A. Malaty MD Michael S. Okun MD 《Neuromodulation》2013,16(1):35-40
Objectives: To screen for potentially underreported behavioral changes in patients with idiopathic Parkinson's disease (PD) pre‐ and post‐deep brain stimulation (DBS), a retrospective data base review was performed. Methods: In total, 113 patients who underwent unilateral or bilateral DBS at the University of Florida in either subthalamic nucleus or globus pallidus internus for PD were screened for behavioral issues by asking about the presence or absence of seven neuropsychiatric symptoms (panic, fear, paranoia, anger, suicidal flashes, crying, and laughing). Results: There was a high prevalence of fear (16.3%), panic (14.0%), and anger (11.6%) at baseline in this cohort. In the first six months following DBS implantation, anger (32.6%), fear (26.7%), and uncontrollable crying (26.7%) were the most frequent symptoms reported. Those symptoms also were present following six months of DBS surgery (30.2%, 29.1%, and 19.8%, respectively). New uncontrollable crying occurred more in the acute postoperative stage (less than or equal to six months) (p= 0.033), while new anger occurred more in the chronic postoperative stage (greater than six months) (p= 0.017). The frequency of uncontrollable laughing significantly increased with bilateral DBS (p= 0.033). Conclusions: Many of the neuropsychiatric issues were identified at preoperative baseline and their overall occurrence was more than expected. There was a potential for worsening of these issues post‐DBS. There were subtle differences in time course, and in unilateral vs. bilateral implantations. Clinicians should be aware of these potential behavioral issues that may emerge following DBS therapy, and should consider including screening questions in preoperative and postoperative interviews. Standardized scales may miss the presence or absence of these clinically relevant issues. 相似文献
82.
Acute ultrastructural and behavioral effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mice 总被引:5,自引:0,他引:5
Acute actions of MPTP on behavior and on neostriatal ultrastructure were examined in young C57 Black mice. Autonomic, motor, and toxic effects of MPTP exhibited dependence on dose (20-40 mg/kg) and time during the first 4 h after subcutaneous injection. The ultrastructure of the neostriatum was altered very quickly (2-24 h) after single injections of MPTP. Darkened glial processes were found within 2-8 h, followed by dark degeneration of synaptic boutons, especially those making small symmetric synapses. More rarely, swollen axons and postsynaptic degeneration were also observed. 相似文献
83.
Patterns of illness in parent-child pairs both hospitalized for either schizophrenia or a major mood disorder. 总被引:2,自引:0,他引:2
Results are reported of a blind rediagnosis of a consecutive series of parent-child pairs hospitalized with a diagnosis of schizophrenia or mood disorder. Patterns of illness in pairs meeting DSM-III-R criteria for either disorder were examined by contrasting the two generations on their respective distributions of diagnoses, and means of age at onset and severity of illness. While no case of mood disorder was found in the children of schizophrenic parents, 50% of the children of parents with psychotic mood disorders presented with schizophrenia. The offspring also had an earlier age at onset of illness than did their parents. 相似文献
84.
85.
Aaron U. Blackham MD Gregory B. Russell MS John H. Stewart IV MD Konstantinos Votanopoulos MD Edward A. Levine MD Perry Shen MD FACS 《Annals of surgical oncology》2014,21(8):2667-2674
Background
Liver resection has long been considered the standard of care for resectable colorectal hepatic metastases (HM). Patients with colorectal peritoneal surface disease (PSD) are now also being treated with aggressive therapy in the form of cytoreductive surgery (CS) and hyperthermic intraperitoneal chemotherapy (HIPEC).Methods
A retrospective comparison of optimally-treated colorectal cancer patients with HM or PSD obtained from prospectively maintained databases (1991–2010).Results
Liver resection was performed on 179 patients with HM, while 93 PSD patients received a complete cytoreduction followed by HIPEC. Patients differed in terms of age, performance status, site of primary cancer, T stage, and the use of perioperative chemotherapy. Five-year overall survival for HM patients was 36 %, with a median survival of 46 months, compared with 26 % and 34 months in patients with PSD (p = 0.024). When stratified by resection status, R0 HM (n = 170) and R0 PSD (n = 48) patients had similar median survival (49 vs. 41 months; p = 0.39). Median survival following R1 resection was also similar among HM (n = 9) and PSD (n = 45) patients (28 vs. 23 months; p = 0.68). Multivariate analysis identified distinctly different independent prognostic factors between HM and PSD patients. Major morbidity was 21 and 23 % (p = 0.88), while mortality was 3.9 versus 5.4 % (p = 0.55) in the HM and PSD patients, respectively.Conclusion
Colorectal HM and PSD are distinct biologic diseases with different presentations and unique prognostic factors. However, long-term survival following CS/HIPEC is comparable to liver resection when stratified by completeness of resection. Furthermore, perioperative morbidity and mortality are similar. 相似文献86.
D. Linder F. Sampogna A. Torreggiani N. Balato L. Bianchi N. Cassano A. Conti P. Gisondi M.L. Musumeci S. Piaserico C. Potenza G.V. Romano U. di Luzio Paparatti 《Journal of the European Academy of Dermatology and Venereology》2012,26(9):1163-1166
Background The last decades have witnessed an increasing interest for the psychosocial aspects of chronic skin diseases, such as psoriasis. Nonetheless, systematic assessments of the impact of psoriasis on patients’ lives are rarely done in daily clinical practice. The existing instruments are mostly meant to be completed by patients alone, and rarely comprise a graphical representation of the results. Objective To develop a questionnaire allowing both a quick assessment of the impact of psoriasis on patients and, at the same time, an intuitive graphic visualization of the outcome of the test. Methods A preliminary version of an Italian questionnaire aimed to assess the global impact of psoriasis on patients, meant to be filled in together by the patient and the dermatologist and to produce visual, intuitive results, was developed through focus groups. The instrument was then the object of a Delphi survey addressed to a panel of experts, to assess both the need of possible improvements of the questionnaire (in terms of the formulations of the questions and of the domains to be explored) and the usefulness of the questionnaire. Results A 10‐item questionnaire in Italian, taking into account different aspects of the burden of psoriasis on the patient, was developed. The answers are given on a 10‐point visual analogue scale and graphically represented on a disc as a polygon. Conclusions A formal validation of the questionnaire and a study to assess potential clinical and psychological benefits of a systematic implementation of the instrument in daily practice are planned. 相似文献
87.
88.
89.
Spatial aspects of oncogenic signalling determine the response to combination therapy in slice explants from Kras‐driven lung tumours 下载免费PDF全文
Katja Närhi Ashwini S Nagaraj Elina Parri Riku Turkki Petra W van Duijn Annabrita Hemmes Jenni Lahtela Virva Uotinen Mikko I Mäyränpää Kaisa Salmenkivi Jari Räsänen Nina Linder Jan Trapman Antti Rannikko Olli Kallioniemi Taija M Af Hällström Johan Lundin Wolfgang Sommergruber Simon Anders Emmy W Verschuren 《The Journal of pathology》2018,245(1):101-113
A key question in precision medicine is how functional heterogeneity in solid tumours informs therapeutic sensitivity. We demonstrate that spatial characteristics of oncogenic signalling and therapy response can be modelled in precision‐cut slices from Kras‐driven non‐small‐cell lung cancer with varying histopathologies. Unexpectedly, profiling of in situ tumours demonstrated that signalling stratifies mostly according to histopathology, showing enhanced AKT and SRC activity in adenosquamous carcinoma, and mitogen‐activated protein kinase (MAPK) activity in adenocarcinoma. In addition, high intertumour and intratumour variability was detected, particularly of MAPK and mammalian target of rapamycin (mTOR) complex 1 activity. Using short‐term treatment of slice explants, we showed that cytotoxic responses to combination MAPK and phosphoinositide 3‐kinase–mTOR inhibition correlate with the spatially defined activities of both pathways. Thus, whereas genetic drivers determine histopathology spectra, histopathology‐associated and spatially variable signalling activities determine drug sensitivity. Our study is in support of spatial aspects of signalling heterogeneity being considered in clinical diagnostic settings, particularly to guide the selection of drug combinations. © 2018 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland. 相似文献
90.
Zhu Y Valdes R Simmons CQ Linder MW Pugia MJ Jortani SA 《Clinica chimica acta; international journal of clinical chemistry》2006,371(1-2):71-78
BACKGROUND: Ligand binding is commonly analyzed using various immunoassays that are generally time-consuming and some may require secondary antibodies or gel electrophoresis which are also time-consuming and sometimes subjective. We introduced various examples for a more rapid approach using pre-activated surface chips which are analyzed by surface enhanced laser desorption/ionization-time of flight mass spectrometry (SELDI-TOF MS). Specific applications presented in this study include immobilization of antigen, antibody or oligo DNA on pre-activated chips with subsequent identification of the binding antibodies, antigens or DNA binding proteins to demonstrate the universal utility of this novel approach. METHODS: BSA-digoxin conjugate (BSA-Dig), anti-digoxin antibody, anti-urinary trypsin inhibitor (uTi) antibody, or a double stranded oligo nucleotide based on the nucleotide sequence between -91 and -10 of the human CYP 450 2E1 promoter were immobilized on the Ciphergen pre-activated surface chips. Anti-digoxin antibody, BSA-digoxin conjugate, uTi, and CYP450 2E1 promoter binding protein were captured on the chip and identified by SELDI-TOF MS. RESULTS: A protein with 141kDa was identified from anti-digoxin serum using BSA-Dig chips. This binding was competitively inhibited by addition of digoxin. Using anti-digoxin antibody, a peak at approximately 66kDa was detected in the preparation of BSA-Dig. This peak was also inhibited by free digoxin, suggesting BSA-Dig is detected. uTi fragments with approximately 3kDa to approximately 30kDa in the standard and urine samples were captured on the chip by anti-uTi antibody. Finally, we identified a 95-kDa CYP 450 2E1 promoter binding protein in HeLa cells nuclear extracts. CONCLUSIONS: Bioaffinity SELDI-TOF MS is a powerful and versatile approach for analysis of ligands. It eliminates tracer-labeled secondary antibodies and allows for determination of molecular weights of binding proteins and their ligands directly. This approach may also be considered for the detection of enzymes, receptors, or any other specific ligands. 相似文献